Health Care Deal News: Spotlight on Pharmaceuticals- April 2012
GlaxoSmithKline continues the sell-off of its generic drugs. In March, it announced selling a portfolio of European over-the-counter drugs to Belgium’s Omega Pharma for approximately $612.0 million. The portfolio includes Solpadeine (pain), Zantac (stomach acid) and...Health Care Deal News: Spotlight on Medical Devices – April 2012
In March’s largest deal in any sector of health care, Boston Scientific (NYSE: BSX) is offering to acquire Cameron Health for as much as $1.35 billion. Based in San Clemente, California, Cameron’s S-ICD wireless system is the only commercially available subcutaneous...Health Care Deal News: Spotlight on Medical Devices – March 2012
Although the Medical Device sector saw robust deal volume in February, the (revealed) prices were rather modest. In the largest deal with a disclosed price, Linden, LLC, a Chicago-based private equity shop, has offered to acquire SeraCare Life Sciences (NASDAQ:...Health Care Deal News: Spotlight on Pharmaceuticals- March 2012
With big pharma concentrating on Biotechnology this month, February saw no grand gestures in the Pharmaceutical M&A market. Impax Laboratories (NASDAQ: IPXL) acquired the U.S. rights to AstraZeneca’s (NYSE: AZN) migraine headache drug, Zomig. It is sold as a...Health Care Deal News- April 23, 2012
Brought to you by www.DealSearchOnline.com April 23, 2012 Issue: Recent Health Care M&A Deals First Quarter M&A Results– 2011 Saw A total of 249 Deals Worth $34.0 Billion Spotlight on: Biotechnology Conference Calendar Recent Health Care...Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
